Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets
Terran to advance the development of two of Sanofi’s Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commercialization in all fields of use NEW YORK, April 21, 2022 /PRNewswire/ — Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has […]
Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets Read More